GRI Bio Operations, Inc.
2 clinical trials · Sponsor
◉ Watch GRI Bio Operations, Inc.
| Record | Firm | Date |
|---|---|---|
| Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF (NCT06331624) | GRI Bio Operations, Inc. | 2024-04-24 |
| Trial to Examine the Effect of Two Doses of GRI-0621 in Patients With Chronic Liver Disease (NCT02949375) | GRI Bio Operations, Inc. | 2015-09-01 |
Track GRI Bio Operations, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.